Wednesday, January 25, 2017

ELGX Abuzz, ESPR Ahead Of Schedule, Tough Times For VIVO

Shares of Meridian Bioscience Inc. (VIVO) plunged over 20% on Wednesday as the company narrowed its profit and revenue forecasts for fiscal 2017.

from RTT - Biotech http://ift.tt/2km1MLr
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)